| 名稱 | ESR1 p.Y537S Reference Standard |
| 型號(hào) | CBP10603 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | ESR1 p.Y537S Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- 羅氏免疫療法獲FDA批準(zhǔn)治療晚期非小細(xì)胞肺癌（NSCLC）
- 【連載-企業(yè)參考品】 神經(jīng)膠質(zhì)瘤的診斷參考品的選擇
- 腫瘤細(xì)胞的體外檢測(cè)檢出率解析
- 腫瘤細(xì)胞到底是如何“轉(zhuǎn)移”的呢？
- 科佰Bcr-AbL激酶細(xì)胞模型助力客戶發(fā)表高分文獻(xiàn)（IF 15.1）
- ERBB2基因檢測(cè)標(biāo)準(zhǔn)品
- 子宮內(nèi)膜癌精準(zhǔn)分子分型標(biāo)準(zhǔn)品，助力POLE基因檢測(cè)
- 人結(jié)腸癌細(xì)胞株試驗(yàn)要點(diǎn)及說明
- 【產(chǎn)品推介】NRAS診斷標(biāo)準(zhǔn)品
- 基因守護(hù)者：抑癌基因TP53
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > Mutation > CBP10603ESR1 p.Y537S Reference Standard
- 詳細(xì)內(nèi)容
CBP10603 | |
| Format | Genomic DNA |
| Description | ESR1, estrogen receptor alpha, modulates response to estrogen and is used as a marker to predict response to endocrine therapy in breast cancer patients. ESR1 fusions are recurrent in breast cancer, and mutations in ESR1 have been associated with decreased response to endocrine therapy in breast cancer. |
| Technical Data | |
| DNA Change | c.1610A>C |
| AA Change | p.Y537S |
| Mutation type | N/A |
| Zygosity | N/A |
| Allelic Frequency | N/A |
| Transcript | N/A |
| Cosmic ID | COSM1074639 |
| Chr position(GRCh37) | N/A |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing | Download for COA |
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
會(huì)員_a.png)